Andrew Jack

Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens

A. Rawstron, P. Hillmen, R. Tute, 2006, Leukemia.